Grace Therapeutics Stock Falls As FDA Declines To Approve Brain Hemorrhage Drug
US FDA declines to approve Grace Therapeutics' drug for a type of stroke
Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance